Author Belka, Claus

1 to 16 of 16 Items
  • 2006 | Journal Article | 
    ​ ​The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro​
    Rübel, A.; Handrick, R.; Lindner, L. H.; Steiger, M.; Eibl, H.; Budach, W. & Belka, C. et al.​ (2006) 
    Radiation Oncology, 1 art. 6​.​ DOI: https://doi.org/10.1186/1748-717X-1-6 
    ​Details  DOI 
  • 2009 | Journal Article | 
    ​ ​Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy​
    Henke, G.; Lindner, L. H.; Vogeser, M.; Eibl, H.-J.; Wörner, J.; Müller, A. C. & Bamberg, M. et al.​ (2009) 
    Radiation Oncology, 4 art. 46​.​ DOI: https://doi.org/10.1186/1748-717X-4-46 
    ​Details  DOI  PMID  PMC 
  • 2010 | Journal Article | 
    ​ ​The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation​
    Rudner, J.; Ruiner, C.-E.; Handrick, R.; Eibl, H.-J.; Belka, C. & Jendrossek, V.​ (2010) 
    Radiation Oncology, 5(108).​ DOI: https://doi.org/10.1186/1748-717X-5-108 
    ​Details  DOI 
  • 2012 | Journal Article | 
    ​ ​Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu/nu mice​
    Henke, G.; Meier, V.; Lindner, L. H.; Eibl, H.; Bamberg, M.; Belka, C. & Budach, W. et al.​ (2012) 
    Radiation Oncology, 7(1) art. 172​.​ DOI: https://doi.org/10.1186/1748-717X-7-172 
    ​Details  DOI 
  • 2013 | Conference Abstract
    ​ ​Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial.​
    Herrlinger, U.; Schaefer, N.; Steinbach, J. P.; Weyerbrock, A.; Hau, P.; Goldbrunner, R. & Friedrich, F. et al.​ (2013)
    Journal of Clinical Oncology, 31(15) , Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    ​Details  WoS 
  • 2014 | Conference Abstract
    ​ ​Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients​
    Herrlinger, U.; Schaefer, N.; Steinbach, J. P.; Weyerbrock, A.; Hau, P.; Goldbrunner, R. & Friedrich, F. et al.​ (2014)
    Journal of Clinical Oncology, 32(15) ​50th Annual Meeting of the American-Society-of-Clinical-Oncology​, Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    ​Details  WoS 
  • 2015 | Journal Article | Research Paper
    ​ ​HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas​
    Ernst, A.; Anders, H.; Kapfhammer, H.; Orth, M.; Hennel, R.; Seidl, K. & Winssinger, N. et al.​ (2015) 
    Cancer Letters, 365(2) pp. 211​-222​.​ DOI: https://doi.org/10.1016/j.canlet.2015.05.024 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article
    ​ ​Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial​
    Herrlinger, U.; Schäfer, N.; Weyerbrock, A.; Hau, P.; Goldbrunner, R.; Friedrich, F. & Rohde, V.  et al.​ (2016) 
    Journal of Clinical Oncology, 34(14) pp. 1611​-1619​.​ DOI: https://doi.org/10.1200/JCO.2015.63.4691 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article | 
    ​ ​On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model​
    Unkel, S.; Belka, C. & Lauber, K.​ (2016) 
    Radiation Oncology, 11 art. 11​.​ DOI: https://doi.org/10.1186/s13014-016-0584-z 
    ​Details  DOI  PMID  PMC  WoS 
  • 2017 | Journal Article
    ​ ​Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma​
    Schäfer, N.; Proescholdt, M.; Steinbach, J. P; Weyerbrock, A.; Hau, P.; Grauer, O. & Goldbrunner, R. et al.​ (2017) 
    Neuro-Oncology, 20(7) pp. 975​-985​.​ DOI: https://doi.org/10.1093/neuonc/nox204 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Age-dependent differences in DNA damage after in vitro CT exposure​
    Gomolka, M.; Oestreicher, U.; Rößler, U.; Samaga, D.; Endesfelder, D.; Lang, P.   & Neumaier, K. et al.​ (2018) 
    International Journal of Radiation Biology, 94(3) pp. 272​-281​.​ DOI: https://doi.org/10.1080/09553002.2018.1419302 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial​
    Schaub, C.; Kebir, S.; Junold, N.; Hattingen, E.; Schäfer, N.; Steinbach, J. P. & Weyerbrock, A. et al.​ (2018) 
    Journal of Cancer Research and Clinical Oncology, 144(8) pp. 1581​-1589​.​ DOI: https://doi.org/10.1007/s00432-018-2671-z 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma​
    Baumeister, P.; Hollmann, A.; Kitz, J. ; Afthonidou, A.; Simon, F.; Shakhtour, J. & Mack, B. et al.​ (2018) 
    Scientific Reports, 8(1).​ DOI: https://doi.org/10.1038/s41598-018-32178-8 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results​
    Walter, F.; Maihöfer, C.; Schüttrumpf, L.; Well, J.; Burges, A.; Ertl-Wagner, B. & Mahner, S. et al.​ (2018) 
    Brachytherapy, 17(5) pp. 775​-781​.​ DOI: https://doi.org/10.1016/j.brachy.2018.05.009 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article
    ​ ​Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial​
    Kebir, S.; Schaub, C.; Junold, N.; Hattingen, E.; Schäfer, N.; Steinbach, J. P. & Weyerbrock, A. et al.​ (2019) 
    Journal of Neuro-Oncology, 144(3) pp. 501​-509​.​ DOI: https://doi.org/10.1007/s11060-019-03246-4 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Efficacy of re-irradiation with carbon ions (RiCi) in patients with recurrent high-grade glioma (rHGG) compared to the standard re-irradiation with photons (RiP): The reference multicenter cohort of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)​
    Knoll, M.; Waltenberger, M.; Bougatf, N.; Bernhardt, D.; Adeberg, S.; Budach, V. & Baumann, M. et al.​ (2019) 
    Journal of Clinical Oncology, 37(15, Suppl.) pp. 2057​-2057​.​ DOI: https://doi.org/10.1200/JCO.2019.37.15_suppl.2057 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100